Magazine Article | April 1, 2022

Platforms To Pipelines: Part 1

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

These days, it seems a majority of R&D platform-based companies also have development pipelines or plans to create one. It is not a foregone outcome. Developing a pipeline of products typically requires much different resources than an organization geared to support early discovery goals such as refining therapeutic modalities or selecting lead candidates. Platforms for post-discovery development usually lack the tools to manage all phases. Why and how do some of those companies tend to go about transforming themselves from technology suppliers into biotherapeutics developers — despite the challenges of such a major change?

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: